[Experimental study of the antineoplastic effect of the antibiotic polymycin].
D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000633:toxicity*; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D001201:Ascites / Q000188:drug therapy; D002279:Carcinoma 256, Walker / Q000188:drug therapy; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D003520:Cyclophosphamide / Q000633:toxicity; D003864:Depression, Chemical; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D007942:Leukemia, Experimental / Q000188:drug therapy; D008466:Mechlorethamine / Q000633:toxicity; D008558:Melphalan / Q000633:toxicity; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D009588:Nitrogen Mustard Compounds / Q000633:toxicity; D051381:Rats; D012509:Sarcoma / Q000188:drug therapy; D012510:Sarcoma 180 / Q000188:drug therapy; D013852:Thiotepa / Q000633:toxicity; D014498:Uracil / Q000633:toxicity
D000900:Anti-Bacterial Agents; D000903:Antibiotics, Antineoplastic; D000935:Antifungal Agents; D000998:Antiviral Agents; D009588:Nitrogen Mustard Compounds; D008466:Mechlorethamine; D014498:Uracil; D003520:Cyclophosphamide; D013852:Thiotepa; D008558:Melphalan
Eksperimental'noe izuchenie protivopukholevoĭ aktivnosti antibiotika polimitsina.